nodes	percent_of_prediction	percent_of_DWPC	metapath
Labetalol—Dobutamine—COMT—attention deficit hyperactivity disorder	0.0125	0.614	CrCbGaD
Labetalol—Lisdexamfetamine—SLC6A3—attention deficit hyperactivity disorder	0.00788	0.386	CrCbGaD
Labetalol—ADRB1—Monoamine GPCRs—DRD4—attention deficit hyperactivity disorder	0.00665	0.00679	CbGpPWpGaD
Labetalol—ADRB2—Monoamine GPCRs—ADRA2A—attention deficit hyperactivity disorder	0.00659	0.00673	CbGpPWpGaD
Labetalol—ADRB2—Monoamine GPCRs—DRD4—attention deficit hyperactivity disorder	0.00651	0.00664	CbGpPWpGaD
Labetalol—ADRB1—Amine ligand-binding receptors—HTR1B—attention deficit hyperactivity disorder	0.0064	0.00653	CbGpPWpGaD
Labetalol—ADRB2—Amine ligand-binding receptors—HTR1B—attention deficit hyperactivity disorder	0.00626	0.00639	CbGpPWpGaD
Labetalol—ADRB1—Monoamine GPCRs—DRD2—attention deficit hyperactivity disorder	0.0062	0.00633	CbGpPWpGaD
Labetalol—ADRB3—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.00615	0.00628	CbGpPWpGaD
Labetalol—ADRB2—Monoamine GPCRs—DRD2—attention deficit hyperactivity disorder	0.00606	0.00619	CbGpPWpGaD
Labetalol—ADRB1—Amine ligand-binding receptors—DRD1—attention deficit hyperactivity disorder	0.00595	0.00607	CbGpPWpGaD
Labetalol—ADRB1—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.00591	0.00603	CbGpPWpGaD
Labetalol—ADRB2—Amine ligand-binding receptors—DRD1—attention deficit hyperactivity disorder	0.00582	0.00594	CbGpPWpGaD
Labetalol—ADRB1—Amine ligand-binding receptors—DRD3—attention deficit hyperactivity disorder	0.00576	0.00588	CbGpPWpGaD
Labetalol—ADRB1—Amine ligand-binding receptors—ADRA2A—attention deficit hyperactivity disorder	0.00566	0.00578	CbGpPWpGaD
Labetalol—ADRB2—Amine ligand-binding receptors—DRD3—attention deficit hyperactivity disorder	0.00564	0.00575	CbGpPWpGaD
Labetalol—ADRB1—Amine ligand-binding receptors—DRD4—attention deficit hyperactivity disorder	0.00559	0.00571	CbGpPWpGaD
Labetalol—ADRB2—Amine ligand-binding receptors—ADRA2A—attention deficit hyperactivity disorder	0.00554	0.00566	CbGpPWpGaD
Labetalol—ADRB2—Amine ligand-binding receptors—DRD4—attention deficit hyperactivity disorder	0.00547	0.00559	CbGpPWpGaD
Labetalol—ADRB1—Amine ligand-binding receptors—DRD2—attention deficit hyperactivity disorder	0.00521	0.00532	CbGpPWpGaD
Labetalol—ADRB2—Amine ligand-binding receptors—DRD2—attention deficit hyperactivity disorder	0.0051	0.0052	CbGpPWpGaD
Labetalol—ADRB1—G alpha (s) signalling events—DRD5—attention deficit hyperactivity disorder	0.00436	0.00445	CbGpPWpGaD
Labetalol—ADRB1—Monoamine GPCRs—HTR2A—attention deficit hyperactivity disorder	0.00434	0.00443	CbGpPWpGaD
Labetalol—ADRB2—G alpha (s) signalling events—DRD5—attention deficit hyperactivity disorder	0.00426	0.00435	CbGpPWpGaD
Labetalol—ADRB2—Monoamine GPCRs—HTR2A—attention deficit hyperactivity disorder	0.00425	0.00434	CbGpPWpGaD
Labetalol—ADRB3—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.00417	0.00426	CbGpPWpGaD
Labetalol—ADRB3—G alpha (s) signalling events—DRD1—attention deficit hyperactivity disorder	0.00413	0.00422	CbGpPWpGaD
Labetalol—ADRB3—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00409	0.00417	CbGpPWpGaD
Labetalol—ADRB3—Calcium Regulation in the Cardiac Cell—CACNA1C—attention deficit hyperactivity disorder	0.00408	0.00417	CbGpPWpGaD
Labetalol—ADRB3—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00406	0.00414	CbGpPWpGaD
Labetalol—ADRB1—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.00365	0.00373	CbGpPWpGaD
Labetalol—ADRB3—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00357	0.00365	CbGpPWpGaD
Labetalol—ADRB2—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.00357	0.00364	CbGpPWpGaD
Labetalol—ADRB3—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.0035	0.00357	CbGpPWpGaD
Labetalol—ADRB2—GPCRs, Other—DRD3—attention deficit hyperactivity disorder	0.00298	0.00304	CbGpPWpGaD
Labetalol—CYP2D6—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.00289	0.00295	CbGpPWpGaD
Labetalol—ADRB2—GPCRs, Other—DRD4—attention deficit hyperactivity disorder	0.00289	0.00295	CbGpPWpGaD
Labetalol—ADRB3—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00283	0.00289	CbGpPWpGaD
Labetalol—ADRB3—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00272	0.00278	CbGpPWpGaD
Labetalol—ADRB3—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00267	0.00272	CbGpPWpGaD
Labetalol—ADRB3—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00248	0.00253	CbGpPWpGaD
Labetalol—ADRB1—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.00248	0.00253	CbGpPWpGaD
Labetalol—ADRB1—G alpha (s) signalling events—DRD1—attention deficit hyperactivity disorder	0.00245	0.00251	CbGpPWpGaD
Labetalol—ADRB3—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00243	0.00248	CbGpPWpGaD
Labetalol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00242	0.00248	CbGpPWpGaD
Labetalol—ADRB1—Calcium Regulation in the Cardiac Cell—CACNA1C—attention deficit hyperactivity disorder	0.00242	0.00247	CbGpPWpGaD
Labetalol—ADRB2—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.00242	0.00247	CbGpPWpGaD
Labetalol—ADRB1—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00241	0.00246	CbGpPWpGaD
Labetalol—ADRB2—G alpha (s) signalling events—DRD1—attention deficit hyperactivity disorder	0.0024	0.00245	CbGpPWpGaD
Labetalol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00237	0.00242	CbGpPWpGaD
Labetalol—ADRB2—Calcium Regulation in the Cardiac Cell—CACNA1C—attention deficit hyperactivity disorder	0.00237	0.00242	CbGpPWpGaD
Labetalol—ADRB2—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00236	0.0024	CbGpPWpGaD
Labetalol—ADRB3—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.0023	0.00235	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00229	0.00234	CbGpPWpGaD
Labetalol—ADRB3—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00223	0.00227	CbGpPWpGaD
Labetalol—ADRB3—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00219	0.00224	CbGpPWpGaD
Labetalol—ADRB3—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00216	0.00221	CbGpPWpGaD
Labetalol—ADRB3—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00212	0.00216	CbGpPWpGaD
Labetalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00212	0.00216	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00208	0.00212	CbGpPWpGaD
Labetalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00208	0.00212	CbGpPWpGaD
Labetalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00207	0.00212	CbGpPWpGaD
Labetalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00203	0.00207	CbGpPWpGaD
Labetalol—ADRB3—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00202	0.00206	CbGpPWpGaD
Labetalol—ADRB3—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00197	0.00201	CbGpPWpGaD
Labetalol—ADRB3—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00191	0.00195	CbGpPWpGaD
Labetalol—ADRB2—GPCRs, Other—HTR2A—attention deficit hyperactivity disorder	0.00189	0.00193	CbGpPWpGaD
Labetalol—ADRB3—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00188	0.00192	CbGpPWpGaD
Labetalol—ADRB3—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00185	0.00189	CbGpPWpGaD
Labetalol—ADRB3—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00185	0.00189	CbGpPWpGaD
Labetalol—ADRB3—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00173	0.00176	CbGpPWpGaD
Labetalol—ADRB1—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00168	0.00172	CbGpPWpGaD
Labetalol—ADRB2—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00164	0.00168	CbGpPWpGaD
Labetalol—ADRB3—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00161	0.00165	CbGpPWpGaD
Labetalol—ADRB1—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00161	0.00165	CbGpPWpGaD
Labetalol—ADRB1—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00158	0.00161	CbGpPWpGaD
Labetalol—ADRB2—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00158	0.00161	CbGpPWpGaD
Labetalol—ADRB2—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00155	0.00158	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00154	0.00157	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00151	0.00154	CbGpPWpGaD
Labetalol—ADRB3—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.0015	0.00153	CbGpPWpGaD
Labetalol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00147	0.0015	CbGpPWpGaD
Labetalol—ADRB3—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00145	0.00148	CbGpPWpGaD
Labetalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00144	0.00147	CbGpPWpGaD
Labetalol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00144	0.00147	CbGpPWpGaD
Labetalol—ADRB3—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00143	0.00146	CbGpPWpGaD
Labetalol—ADRB3—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00141	0.00144	CbGpPWpGaD
Labetalol—ADRB3—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00141	0.00144	CbGpPWpGaD
Labetalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00141	0.00144	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.0014	0.00143	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00137	0.0014	CbGpPWpGaD
Labetalol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00137	0.00139	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00136	0.00139	CbGpPWpGaD
Labetalol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00134	0.00136	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00133	0.00136	CbGpPWpGaD
Labetalol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00132	0.00135	CbGpPWpGaD
Labetalol—ADRB3—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00131	0.00134	CbGpPWpGaD
Labetalol—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00131	0.00134	CbGpPWpGaD
Labetalol—ADRB1—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.0013	0.00133	CbGpPWpGaD
Labetalol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00129	0.00132	CbGpPWpGaD
Labetalol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00128	0.00131	CbGpPWpGaD
Labetalol—ADRB2—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00127	0.0013	CbGpPWpGaD
Labetalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00126	0.00128	CbGpPWpGaD
Labetalol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00126	0.00128	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00124	0.00126	CbGpPWpGaD
Labetalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00123	0.00126	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00123	0.00126	CbGpPWpGaD
Labetalol—ADRB3—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00121	0.00123	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00121	0.00123	CbGpPWpGaD
Labetalol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.0012	0.00122	CbGpPWpGaD
Labetalol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00117	0.00119	CbGpPWpGaD
Labetalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00117	0.00119	CbGpPWpGaD
Labetalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00114	0.00117	CbGpPWpGaD
Labetalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00113	0.00116	CbGpPWpGaD
Labetalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00111	0.00114	CbGpPWpGaD
Labetalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00111	0.00113	CbGpPWpGaD
Labetalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.0011	0.00112	CbGpPWpGaD
Labetalol—ADRB1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.0011	0.00112	CbGpPWpGaD
Labetalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00109	0.00111	CbGpPWpGaD
Labetalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00108	0.0011	CbGpPWpGaD
Labetalol—ADRB2—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00107	0.00109	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00104	0.00107	CbGpPWpGaD
Labetalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00102	0.00105	CbGpPWpGaD
Labetalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.001	0.00102	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00096	0.00098	CbGpPWpGaD
Labetalol—ADRB1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000958	0.000978	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000948	0.000968	CbGpPWpGaD
Labetalol—ADRB2—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000938	0.000957	CbGpPWpGaD
Labetalol—ADRB3—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000921	0.00094	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000913	0.000932	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000913	0.000932	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000894	0.000913	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000893	0.000911	CbGpPWpGaD
Labetalol—ADRB1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000891	0.00091	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000875	0.000893	CbGpPWpGaD
Labetalol—ADRB2—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000872	0.00089	CbGpPWpGaD
Labetalol—ADRB1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000863	0.000881	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000848	0.000866	CbGpPWpGaD
Labetalol—ADRB1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000848	0.000866	CbGpPWpGaD
Labetalol—ADRB2—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000844	0.000862	CbGpPWpGaD
Labetalol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000838	0.000855	CbGpPWpGaD
Labetalol—ADRB1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000838	0.000855	CbGpPWpGaD
Labetalol—ADRB2—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00083	0.000847	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000829	0.000846	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000829	0.000846	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000825	0.000842	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000822	0.000839	CbGpPWpGaD
Labetalol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00082	0.000837	CbGpPWpGaD
Labetalol—ADRB2—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00082	0.000837	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000812	0.000829	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000811	0.000828	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000808	0.000825	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000808	0.000824	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000798	0.000814	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000794	0.000811	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000792	0.000809	CbGpPWpGaD
Labetalol—ADRB1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00078	0.000797	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00077	0.000786	CbGpPWpGaD
Labetalol—ADRB2—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000763	0.000779	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000746	0.000762	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000743	0.000759	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000733	0.000749	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00073	0.000745	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000724	0.000739	CbGpPWpGaD
Labetalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000718	0.000733	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000714	0.000729	CbGpPWpGaD
Labetalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000702	0.000717	CbGpPWpGaD
Labetalol—CYP2D6—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000701	0.000716	CbGpPWpGaD
Labetalol—CYP2D6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000696	0.000711	CbGpPWpGaD
Labetalol—CYP2D6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000692	0.000706	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000675	0.000689	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00062	0.000633	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000606	0.000619	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00057	0.000582	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000563	0.000574	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.00056	0.000572	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000557	0.000569	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00055	0.000562	CbGpPWpGaD
Labetalol—ADRB1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000547	0.000558	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000542	0.000553	CbGpPWpGaD
Labetalol—ADRB2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000535	0.000546	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00053	0.000541	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.00052	0.000531	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000504	0.000514	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000493	0.000503	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000492	0.000502	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.00049	0.0005	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00049	0.0005	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000488	0.000498	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000481	0.000491	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00048	0.00049	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000479	0.000489	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000479	0.000489	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000477	0.000487	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000473	0.000483	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000473	0.000482	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00047	0.00048	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000469	0.000479	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000469	0.000479	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000463	0.000473	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00046	0.00047	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000457	0.000467	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000455	0.000465	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000447	0.000457	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000443	0.000452	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000441	0.00045	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000441	0.00045	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000435	0.000444	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000433	0.000442	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000433	0.000442	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000431	0.00044	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00043	0.000439	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000428	0.000437	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000426	0.000435	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000421	0.000429	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000401	0.000409	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000399	0.000407	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000392	0.0004	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000332	0.000339	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000325	0.000332	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000309	0.000315	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000302	0.000308	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000291	0.000297	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000287	0.000293	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000284	0.00029	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000281	0.000286	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000279	0.000285	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000274	0.00028	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.00027	0.000276	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000264	0.00027	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000262	0.000267	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000257	0.000263	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000256	0.000261	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000254	0.000259	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000252	0.000257	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000248	0.000254	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000237	0.000242	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000231	0.000236	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000198	0.000202	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000198	0.000202	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000195	0.000199	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000181	0.000185	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000166	0.000169	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000162	0.000165	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000158	0.000162	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000151	0.000154	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000148	0.000151	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	0.00012	0.000122	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000119	0.000122	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	8.78e-05	8.96e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	8.59e-05	8.77e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	5.14e-05	5.25e-05	CbGpPWpGaD
